Pharmacokinetics of new oral anticoagulants: implications for use in routine care
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics of new oral anticoagulants: implications for use in routine care
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 14, Issue 10, Pages 1057-1069
Publisher
Informa UK Limited
Online
2018-10-02
DOI
10.1080/17425255.2018.1530213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation
- (2018) Jordanne Feldberg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis
- (2017) Giuseppe Andò et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
- (2017) Xiaoxi Yao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactions
- (2016) Reinhold Kreutz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study
- (2016) Ziv Harel et al. CANADIAN JOURNAL OF CARDIOLOGY
- Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study
- (2016) Craig I. Coleman et al. CURRENT MEDICAL RESEARCH AND OPINION
- The safety and persistence of non-vitamin-K-antagonist oral anticoagulants in atrial fibrillation patients treated in a well structured atrial fibrillation clinic
- (2016) Faris Al-Khalili et al. CURRENT MEDICAL RESEARCH AND OPINION
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation — The RELIEF study
- (2016) Craig I. Coleman et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- THE IMPACT OF BODY WEIGHT ON ADVERSE OUTCOMES WITH NOVEL ORAL ANTICOAGULANTS AND WARFARIN: PRELIMINARY RESULTS FROM THE INTEGRATE STUDY
- (2016) Yining Xu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
- (2016) Kevin E. Chan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin
- (2016) Barbara S. Wiggins et al. PHARMACOTHERAPY
- Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC
- (2016) Anja Katholing et al. THROMBOSIS AND HAEMOSTASIS
- Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation
- (2016) J. Hecker et al. THROMBOSIS AND HAEMOSTASIS
- Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
- Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
- Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
- (2016) Joshua D. Brown et al. Journal of Managed Care & Specialty Pharmacy
- Experimental and clinical pharmacology: New oral anticoagulant drugs - mechanisms of action
- (2016) Timothy Brighton Australian Prescriber
- Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation
- (2015) G. Y. H. Lip et al.
- Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications
- (2015) Concetta Crivera et al. CURRENT MEDICAL RESEARCH AND OPINION
- Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure
- (2015) Colleen A. McHorney et al. CURRENT MEDICAL RESEARCH AND OPINION
- Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry
- (2015) J. Beyer-Westendorf et al. EUROPACE
- Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
- (2015) Hein Heidbuchel et al. EUROPACE
- XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
- (2015) A. John Camm et al. EUROPEAN HEART JOURNAL
- Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study
- (2015) S. Corrao et al. European Journal of Internal Medicine
- End-stage renal disease and thrombophilia
- (2015) A. Bauer et al. Hamostaseologie
- Net clinical benefit of edoxaban versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
- (2015) Andrew D. Blann et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study
- (2015) A. Gorst-Rasmussen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale
- (2015) Lana A. Castellucci et al. THROMBOSIS RESEARCH
- Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation
- (2015) G. Y. H. Lip et al. Circulation-Cardiovascular Quality and Outcomes
- Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration
- (2014) Supriya Shore et al. AMERICAN HEART JOURNAL
- Appropriateness of Prescribing Dabigatran Etexilate and Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation
- (2014) Anne-Sophie Larock et al. ANNALS OF PHARMACOTHERAPY
- Novel Oral Anticoagulants in Patients With Renal Insufficiency: A Meta-analysis of Randomized Trials
- (2014) Partha Sardar et al. CANADIAN JOURNAL OF CARDIOLOGY
- Challenges and Priorities for Research
- (2014) Brian W. McCrindle et al. CIRCULATION
- Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
- (2014) Winnie W. Nelson et al. CURRENT MEDICAL RESEARCH AND OPINION
- Coadministration of Dabigatran Etexilate and Atorvastatin
- (2013) Joachim Stangier et al. American Journal of Cardiovascular Drugs
- Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
- (2013) Martin Zalesak et al.
- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
- (2013) Torben Bjerregaard Larsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adherence to anticoagulant treatment with dabigatran in a real-world setting
- (2013) S. Schulman et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran and Postmarketing Reports of Bleeding
- (2013) Mary Ross Southworth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatrán frente a warfarina en pacientes con válvulas cardiacas mecánicas
- (2013) D. Fernández de Velasco Pérez REVISTA CLINICA ESPANOLA
- Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
- (2012) Morten Lamberts et al. CIRCULATION
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- New anticoagulants in children: A review of recent studies and a look to the future
- (2010) Guy Young THROMBOSIS RESEARCH
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation
- (2009) Alan S. Go et al. CIRCULATION
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
- (2009) S. G. Aller et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started